Osborne Clarke advised PCM Trials on the acquisition of Clinical Trial Service

Osborne Clarke has advised PCM TRIALS - Quality Mobile Research, a USA-based leading company in the field of providing mobile research nurses for decentralized clinical trials (DCTs), on the acquisition of Clinical Trial Service B.V., a Dutch company with over 30 years of experience in managing and staffing global clinical trials for clinical operations and with GCP-trained mobile research nurses for DCTs in over 80 countries.

With this acquisition, PCM Trials extends its extensive global footprint to become the most experienced independent provider of mobile visit services with the largest geographic coverage area in support of DCTs and will allow PCM Trials to make available the most direct nursing model on a global scale.

Herke Van Hulst commented: "We are very proud to have been able to support our long standing client PCM Trials."

Christy Crase, Senior Vice President & General Counsel of PCM Trials commented: "It has been an absolute pleasure to work with the OC team and really appreciated the professionalism, expertise and hard work in handling this important strategic transaction for PCM Trials and CTS."

The Osborne Clarke core deal team assisting our long standing client PCM Trials included partner Herke van Hulst and senior associate Wouter Kok and associates Angela Saldanha and Saliha El Morabit (corporate M&A). Other members of the Osborne Clarke team who assisted on the transaction are partner Job van der Pol and associate Sjoerd Waagmeester (Tax), partner/civil-law notary Cars-Jan van Gool and associate Eveline Leijen (Notarial), partner Joanne Zaaijer and associate Doddy Wolfs (Data Protection), partner Jim Margry and senior associate Wyke Schilstra (Employment), senior associate Casper Bos (Real Estate) and partner Coen Barneveld Binkhuysen, senior associate Sophie den Held and associate Gianna Hendriks (Commercial and IP/IT) and Life Science partner of OC Paris Thomas Devred (Regulatory and Compliance). 

Osborne Clarke is widely recognised as a leading international law firm for companies operating in the life science and healthcare sector. Its sector team has a strong track record of providing highly sophisticated advice to clients on cutting-edge transactions, across multiple service lines. They work with blue chip venture capital firms, the biggest health, pharma and medical research companies in the market.